Evidence map›Paper›PMID 35940286›Full record

ArticleInternational journal of psychiatry in medicine2023

COVID-19 vaccine compliance in adolescents with attention-deficit/hyperactivity disorder.

Vered Shkalim Zemer, Moshe Hoshen, Maya Gerstein, Yael Richenberg, Eyal Jacobson, Roy Grossu, Moriya Cohen, Herman Avner Cohen

Open access · greenAbstract read
In one paragraph

Article in International journal of psychiatry in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vered Shkalim ZemerDan-Petach-Tikva District, Clalit Health Services, Petach Tikva, Israel.ORCID 0000-0003-1733-5395
Moshe HoshenDan-Petach-Tikva District, Clalit Health Services, Petach Tikva, Israel.
Maya Gerstein58408Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Yael RichenbergDan-Petach-Tikva District, Clalit Health Services, Petach Tikva, Israel.
Eyal JacobsonDan-Petach-Tikva District, Clalit Health Services, Petach Tikva, Israel.
Roy GrossuDan-Petach-Tikva District, Clalit Health Services, Petach Tikva, Israel.
Moriya Cohen42732Ariel University, Ariel, Israel.
Herman Avner Cohen58408Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Clalit Health Services · ILTel Aviv University · ILAriel University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the rate of the administration of the Pfizer-BioNTech COVID-19 vaccinations between adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) and non-ADHD subjects.

methodA retrospective chart review was performed on all adolescents aged 12-17 years registered at a central district in Israel from January 1

resultsOf the 46,544 subjects included in the study, 8241 (17.7%) were diagnosed with ADHD. Of them, 3% were PCR-COVID-19 positive. Among the patients with ADHD, the older adolescents were more likely to be vaccinated: 48.8% of those aged 12-15 years were vaccinated versus 59.6% of patients aged 16-17 years. The ultra-orthodox Jewish and Arab adolescents in the ADHD group were far less likely to be vaccinated (22.9% and 34.6%, respectively), compared to the adolescents with ADHD in the general population (60.5%). Girls were also somewhat more likely to be vaccinated.

conclusionsAdolescents diagnosed with ADHD had a higher COVID-19 vaccination rate compared to their non-ADHD counterparts. The vaccine uptake was lower amongst Arab and ultra-orthodox Jewish populations.

Indexed as

Attention Deficit Disorder with HyperactivityCOVID-19AdolescentCOVID-19 VaccinesFemaleHumansPatient ComplianceRetrospective StudiesCOVID-19 VaccinesADHDadolescentsCOVID-19vaccination

Identifiers

PMID35940286
PMCPMC9364072
OpenAlexW4290694752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.